Skip to main content


A pilot study found evidence of Bartonella infection in the blood of participants with schizophrenia, fueling researchers’ hypothesis that there may be a connection between bacterial infection and neuropsychiatric disease.
Christoph U. Correll, MD, explains the importance of medication adherence in patients taking antipsychotics, how long-acting injectables (LAIs) improve adherence, and strategies for educating patients on LAIs.
Schizophrenia and personality disorders had the highest burdens of disability among individuals with mental health or substance use disorders, according to a new analysis published in The Lancet Psychiatry.
In this Q&A, corresponding author Christoph U. Correll, MD, explains his meta-analysis that found the presence of metabolic syndrome is significantly associated with cognitive dysfunction in individuals with schizophrenia.
Positive and Negative Syndrome Scale total scores dropped an additional 11.6 points in patients with schizophrenia who received combination xanomeline-trospium, compared with placebo, according to a published study.
What does in utero malnutrition have to do with schizophrenia? And why is weight gain, a problematic adverse event, also linked with clinical effectiveness of antipsychotic medications?
Why do so many antipsychotic medications induce symptoms, signs, and physiologic changes that are already present to a lesser degree in the disease states that they are intended to treat?
Back to Top